FDA Inspection
Rentschler Biopharma SERentschler Biopharma SE – FDA Inspection, May 23, 2017
Record Details
This FDA Inspection record concerns Rentschler Biopharma SE, with an inspection on May 23, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Diane L. Raccasi (Issuing Officer)
- Maria J. Lopez- Barragan (Issuing Officer)
- Maxwell L. Van Tassell (Issuing Officer)
View Company Profile
ID · f2b2eb28-9fc0-4b27-a968-da94072cd325
Inspection Facts
- Inspection number
- 1022082
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Rentschler Biopharma SE
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2023 | Not classified | Office of Inspections and Investigations | |
| February 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 9, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Rentschler Biopharma SE
- FDA Inspection 1246782 - 2023-05-05
- FDA Inspection 1202157 - 2023-03-07
- FDA Inspection 1160831 - 2021-02-26
- FDA Inspection 1102650 - 2019-08-09
- FDA Inspection 1046488 - 2018-03-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.